| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Climb Bio, Inc.
13D/A
Amendment 5
CLYM · 28658R106
|
0% |
10/16/2025
Event 10/14/2025
|
|||
| AI Eti LLC | 0% | ||||
| Access Industries Holdings LLC | 0% | ||||
| Access Industries Management, LLC | 0% | ||||
| Len Blavatnik | 0% | ||||
|
Climb Bio, Inc.
13D/A
Amendment 4
CLYM · 28658R106
|
5.7% |
10/7/2025
Event 10/3/2025
|
|||
| AI Eti LLC | 5.7% | ||||
| Access Industries Holdings LLC | 5.7% | ||||
| Access Industries Management, LLC | 5.7% | ||||
| Len Blavatnik | 5.7% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.